SCHEMBL17449762

SCHEMBL17449762

[2H][13C]([2H])(I)C[13CH2][C@@H]([15NH]C(=O)OC(C)(C)C)C(=O)OC(C)(C)C

nearest known ligand 0.48

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CTSK P43235 12/20 0.48
CTSS P25774 5/20 0.46
ATM Q13315 1/20 0.41
TDP1 Q9NUW8 1/20 0.41
P2RY2 P41231 1/20 0.41
CYP1A2 P05177 1/20 0.41
CYP2C9 P11712 1/20 0.41
CYP2C19 P33261 1/20 0.41
HTT P42858 1/20 0.41
HDAC4 P56524 2/20 0.41
HDAC1 Q13547 2/20 0.41
HDAC6 Q9UBN7 1/20 0.41
MEN1 O00255 2/20 0.40
KMT2A Q03164 2/20 0.40
POLB P06746 1/20 0.40
NPSR1 Q6W5P4 1/20 0.40
CA1 P00915 1/20 0.40
CA2 P00918 1/20 0.40
CA7 P43166 1/20 0.40
CTSL P07711 1/20 0.39

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL5031623 0.89 CTSK (0.51) CTSKCTSSATMTDP1P2RY2
SCHEMBL19695766 0.89 CTSK (0.51) CTSKCTSSATMTDP1P2RY2
SCHEMBL6791464 0.89 CTSK (0.51) CTSKCTSSATMTDP1P2RY2
SCHEMBL6791457 0.89 CTSK (0.51) CTSKCTSSATMTDP1P2RY2
SCHEMBL17449771 0.86 CTSK (0.49) CTSKCTSSATMTDP1P2RY2
SCHEMBL14682825 0.86 CTSK (0.49) CTSKCTSSATMTDP1P2RY2
SCHEMBL30788958 0.84 CTSK (0.46) CTSKCTSSATMTDP1P2RY2
SCHEMBL11506791 0.83 CTSK (0.49) CTSKCTSSATMTDP1P2RY2
SCHEMBL19695765 0.83 CTSK (0.51) CTSKCTSSATMTDP1P2RY2
SCHEMBL17614512 0.83 CTSK (0.67) CTSKCTSS

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20160016890-A1 LYSINE ISOTOPOLOGUES, COMPOSITIONS COMPRISING THE SAME AND METHODS OF SYNTHESIS CAMBRIDGE ISOTOPE LABORATORIES, INC. 2016-01-21 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20160016890-A1 LYSINE ISOTOPOLOGUES, COMPOSITIONS COMPRISING THE SAME AND METHODS OF SYNTHESIS PLOD1, PHYKPL, AADAT CTSK 785/4885CTSS 2046/4885ATM 1888/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.